Renal dialysis

DaVita to Further Elevate its Home Dialysis Care Experience with New Baxter Technology

Retrieved on: 
Monday, May 10, 2021
Medicine, Clinical medicine, Medical specialties, Nephrology, Renal dialysis, Membrane technology, Organ failure, Detoxification, Dialysis, Home hemodialysis, DaVita Inc., Peritoneal dialysis

"\nFor many patients with kidney failure, choosing a home dialysis treatment option may provide a better quality of life.

Key Points: 
  • "\nFor many patients with kidney failure, choosing a home dialysis treatment option may provide a better quality of life.
  • Peritoneal dialysis (PD), the most popular at-home dialysis treatment, is a needle-free option that replicates natural kidney function.
  • Through DaVita Kidney Care, the company treats patients with chronic kidney failure and end stage kidney disease.
  • DaVita is committed to bold, patient-centric care models, implementing the latest technologies and moving toward integrated care offerings for all.

Mar Cor Launches Its Newest and Most Advanced Portable Reverse Osmosis Water System

Retrieved on: 
Thursday, May 6, 2021
Medical Supplies, Consumer electronics, Medical devices, Health, Technology, Hospitals, Membrane technology, Chemistry, Physical sciences, Medicine, Renal dialysis, Water technology, Water treatment, Nephrology, Hemodialysis, Home hemodialysis, Cantel Medical Corporation, Dialysis, Cantel Medical, Mar Cor, CANTEL MEDICAL, MAR COR

b'Mar Cor Purification, Inc., a Cantel Medical Corp. (NYSE: CMD ) business, announces the launch of the EON\xe2\x84\xa2 Portable Dialysis Water System.

Key Points: 
  • b'Mar Cor Purification, Inc., a Cantel Medical Corp. (NYSE: CMD ) business, announces the launch of the EON\xe2\x84\xa2 Portable Dialysis Water System.
  • The portable water purification device uses reverse osmosis (RO) to remove organic and inorganic substances and microbial contaminants from water that feeds into hemodialysis machines to treat hemodialysis patients or related therapies.
  • View the full release here: https://www.businesswire.com/news/home/20210506005746/en/\nEON Portable Dialysis Water System from Mar Cor produces high-quality medical water for acute and home hemodialysis use.
  • For easy transport and mobility, combine the EON Water System with Mar Cor\xe2\x80\x99s ROVER\xe2\x84\xa2 Dialysis Water Transport System.

Rockwell Medical, Inc. to Report First Quarter 2021 Financial and Operating Results on May 17, 2021

Retrieved on: 
Monday, May 3, 2021
Medicine, Clinical medicine, Membrane technology, Renal dialysis, Rockwell Medical, Hemodialysis, Dialysis, Intravenous therapy, Home hemodialysis

A live webcast of the call will be available under "Events & Presentations" in the Investor section of the Company\'s website, https://ir.rockwellmed.com/ .

Key Points: 
  • A live webcast of the call will be available under "Events & Presentations" in the Investor section of the Company\'s website, https://ir.rockwellmed.com/ .
  • The Company has two FDA-approved therapies indicated for patients undergoing hemodialysis, which are the first two products developed from the FPC platform.
  • Rockwell Medical is also advancing its FPC platform by developing FPC for the treatment of iron deficiency anemia in patients outside of dialysis, who are receiving intravenous medications in the home infusion setting.
  • In addition, Rockwell Medical is one of two major suppliers of life-saving hemodialysis concentrate products to kidney dialysis clinics in the United States.

Dialysis Market Revenue to Cross USD 114 Bn by 2027: Global Market Insights Inc.

Retrieved on: 
Tuesday, April 27, 2021
Medicine, Clinical medicine, Renal dialysis, Membrane technology, Nephrology, Detoxification, Dialysis, Home hemodialysis, Hemodialysis, Peritoneal dialysis, Northwest Kidney Centers

b'SELBYVILLE, Del., April 27, 2021 /PRNewswire/ --According to the latest report "Dialysis Market by Type (Hemodialysis, Peritoneal Dialysis), Product & Service (Equipment, Consumables, Services), End-use (In-center Dialysis, Home Dialysis), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2027", by Global Market Insights Inc., the market valuation of dialysis will cross $114 billion by 2027.

Key Points: 
  • b'SELBYVILLE, Del., April 27, 2021 /PRNewswire/ --According to the latest report "Dialysis Market by Type (Hemodialysis, Peritoneal Dialysis), Product & Service (Equipment, Consumables, Services), End-use (In-center Dialysis, Home Dialysis), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2027", by Global Market Insights Inc., the market valuation of dialysis will cross $114 billion by 2027.
  • Similarly, availability of efficient dialysis services in dialysis centers and home settings has led to an increased demand for such services among the patient population for effective patient care.\nHome dialysis segment in the dialysis market accounted for more than USD 24 billion in 2020.
  • Additionally, home dialysis offers numerous benefits including flexible schedule, and patient mobility that further secures the segment growth.\nAsia Pacific dialysis market captured over 27% of revenue share in 2020.
  • These market leaders are focusing on developing innovative products that helps the company increase its revenue share internationally.\nTable of Contents (ToC) of the report:\n'

DocGo's Subsidiary Ambulnz Launches Service in Wisconsin

Retrieved on: 
Thursday, April 22, 2021
Medicine, Clinical medicine, Membrane technology, Renal dialysis, Detoxification, Dialysis, Nephrology

The company\'sproprietary artificial intelligence (AI) technology provides intelligent fleet routing, accurate ETAs, and real-time vehicle GPS tracking for enhanced patient engagement and peace of mind.

Key Points: 
  • The company\'sproprietary artificial intelligence (AI) technology provides intelligent fleet routing, accurate ETAs, and real-time vehicle GPS tracking for enhanced patient engagement and peace of mind.
  • Dialysis patients in Wisconsin using Ambulnz services can now get dedicated and reliable transportation to and from their kidney dialysis appointments.\n"The expansion into Wisconsin demonstrates our ongoing contribution to transforming the patient experience.
  • Ambulnz is now is helping patients get to where they need to be, when they need to be there, in order to improve their quality of life.
  • Together with DocGo\'s integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care.

Global $127.4 Billion Dialysis Market Insights & Forecasts to 2024 Featuring Fresenius Medical Care, DaVita, Baxter International, B.Braun, Asahi Kasei, & Nipro

Retrieved on: 
Monday, April 12, 2021
Clinical medicine, Medicine, Medical specialties, Renal dialysis, Membrane technology, Hemodialysis, Home hemodialysis, Dialysis, DaVita Inc., Peritoneal dialysis, Kidney transplantation, Chronic kidney disease

b'DUBLIN, April 12, 2021 /PRNewswire/ -- The "Global Dialysis Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com\'s offering.\nThe global dialysis market is estimated to reach US$127.4 billion in 2024, growing at a CAGR of 6.29% for the period spanning from 2020 to 2024.\nThe factors such as higher prevalence among aging population, increasing diabetic population, rising healthcare spending and increasing cases of ESRD are expected to drive the market.\nHowever, growth of the industry will be challenged by high treatment costs, stringent regulations and rising kidney transplantation procedures.

Key Points: 
  • b'DUBLIN, April 12, 2021 /PRNewswire/ -- The "Global Dialysis Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com\'s offering.\nThe global dialysis market is estimated to reach US$127.4 billion in 2024, growing at a CAGR of 6.29% for the period spanning from 2020 to 2024.\nThe factors such as higher prevalence among aging population, increasing diabetic population, rising healthcare spending and increasing cases of ESRD are expected to drive the market.\nHowever, growth of the industry will be challenged by high treatment costs, stringent regulations and rising kidney transplantation procedures.
  • A few notable trends include rising demand for home dialysis, favorable reimbursement structure, technological advancements and preference of dialysis treatment over the transplant.\nThe global dialysis market is segmented into hemodialysis and peritoneal dialysis.
  • The global dialysis market is highly dominated by hemodialysis owing to a preference for dialysis treatment over transplant, rising prevalence of kidney diseases and a rising number of dialysis centers.\nThe global dialysis market is expected to grow in future due to the growing number of patients suffering from diabetes, increasing healthcare expenditure and rising awareness regarding kidney diseases.
  • In terms of geographical areas, North America and Europe are major contributors to the global dialysis market supported by growing cases of end-stage renal diseases and surge in funding for the development of new products with advanced technology.\nThe report provides a comprehensive analysis of the global dialysis market, segmented into hemodialysis and peritoneal dialysis.\nThe major regional markets (North America, EMEA and the Asia Pacific) have been analyzed.\nThe market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.\nThe competitive landscape of the market, along with the company profiles of leading players (Fresenius Medical Care AG & Co. KGaA, DaVita Inc., Baxter International Inc., B.Braun , Asahi Kasei Corporation, Nipro Corporation) are also presented in detail.\n'

Spectral Medical’s Dialco Medical Announces 20 Year Exclusive License Agreement for DIMI Hemodialysis System in the United States and Canada

Retrieved on: 
Thursday, April 8, 2021
Medicine, Membrane technology, Clinical medicine, Renal dialysis, Natural sciences, Detoxification, Dialysis, Hemodialysis, Dimi, Food and Drug Administration

TORONTO, April 08, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (Spectral or the Company) (TSX: EDT), today announced that its wholly-owned subsidiary, Dialco Medical Inc. (Dialco) has entered into an expanded, long-term licensing agreement with Infomed SA (Infomed) for the DIMI hemodialysis system, extending Dialcos exclusive rights in the United States and Canada through 2041.

Key Points: 
  • TORONTO, April 08, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (Spectral or the Company) (TSX: EDT), today announced that its wholly-owned subsidiary, Dialco Medical Inc. (Dialco) has entered into an expanded, long-term licensing agreement with Infomed SA (Infomed) for the DIMI hemodialysis system, extending Dialcos exclusive rights in the United States and Canada through 2041.
  • Dialco recently received 510(k) clearance by the United States Food & Drug Administration (FDA) for DIMI for use within a wide variety of settings including hospitals, clinics, and skilled nursing facilities.
  • In March 2021, Dialco obtained its DIMI Health Canada license for use in Canadian hospitals, clinics and in home.
  • There remains one final Health Canada license for DIMI to unlock the full dialysis modality of the device.

Global Dialysis Market Insights & Forecasts Report 2020-2024 - Rising Demand for Home Dialysis / Favorable Reimbursement Structure / Technological Advancements - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 8, 2021
Managed care, Health, Medicine, Clinical medicine, Renal dialysis, Membrane technology, Nephrology, Hemodialysis, Dialysis, Home hemodialysis, Peritoneal dialysis, Northwest Kidney Centers, End Stage Renal Disease Program

The "Global Dialysis Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Dialysis Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.
  • A few notable trends include rising demand for home dialysis, favorable reimbursement structure, technological advancements and preference of dialysis treatment over the transplant.
  • The global dialysis market is highly dominated by hemodialysis owing to a preference for dialysis treatment over transplant, rising prevalence of kidney diseases and a rising number of dialysis centers.
  • The report provides a comprehensive analysis of the global dialysis market, segmented into hemodialysis and peritoneal dialysis.

Innovative Renal Care Acquires Kidney Treatment Center of San Antonio

Retrieved on: 
Tuesday, April 6, 2021
General Health, Health, Other Health, Medicine, Membrane technology, Clinical medicine, Medical specialties, Detoxification, Dialysis, Kidney, Nephrology, Renal dialysis, Northwest Kidney Centers, Artificial kidney, Innovative Renal Care, Kidney Treatment Center San Antonio

Innovative Renal Care (IRC), a brand of American Renal Associates (ARA), announced today its acquisition of the assets of Kidney Treatment Center of San Antonio (KTC), an independently owned and operated patient-centered renal dialysis company offering highly personalized care to patients across three dialysis centers in San Antonio.

Key Points: 
  • Innovative Renal Care (IRC), a brand of American Renal Associates (ARA), announced today its acquisition of the assets of Kidney Treatment Center of San Antonio (KTC), an independently owned and operated patient-centered renal dialysis company offering highly personalized care to patients across three dialysis centers in San Antonio.
  • The three clinics, which are currently accepting new patients, will be renamed as IRC San Antonio - Medical Drive, IRC San Antonio - Castroville Road and IRC San Antonio - South New Braunfels.
  • Innovative Renal Care (IRC), an ARA brand, is a pioneering network of dialysis professionals devoted to helping people with kidney disease lead their best lives as they undergo treatment.
  • Our three Kidney Treatment Centers offer a variety of services to patients with end stage renal disease.

NKF Applauds White House Initiative to Vaccinate Dialysis Patients In-Center Nationwide

Retrieved on: 
Thursday, March 25, 2021
Membrane technology, Medicine, Clinical medicine, Detoxification, Dialysis, Kidney, Branches of biology, Renal dialysis, Nephrology, Northwest Kidney Centers, American Kidney Fund

NEW YORK, March 25, 2021 /PRNewswire/ -- Today, the National Kidney Foundation applauds the Biden Administration's announcement of its new partnership with dialysis clinics nationwide to facilitate COVID-19 vaccination of patients with kidney failure .

Key Points: 
  • NEW YORK, March 25, 2021 /PRNewswire/ -- Today, the National Kidney Foundation applauds the Biden Administration's announcement of its new partnership with dialysis clinics nationwide to facilitate COVID-19 vaccination of patients with kidney failure .
  • In addition, minority populations, who are already at increased risk of COVID-19, are over-represented among dialysis patients.
  • It is vital that dialysis facilities, among other sites where kidney patients receive care, have the support and supplies needed to expeditiously implement priority vaccinate practices.
  • More than 500,000 of these patients receive dialysis at least three times per week to replace kidney function.